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Summary
Melissa officinalis, a perennial plant in the family Lamiacae, known 
as lemon balm, is a popular herb with multiple therapeutic properties. 
Significant content of active compounds (including rosmarinic acid) 
is reported to be responsible for the broad health effects of lemon 
balm. Melissa officinalis has antioxidant, anti-inflammatory, anti- 
microbial and antidepressant activities. It can be used in the treat-
ment of sleep disorders, neurodegenerative diseases and obesity as 
well as in ophthalmology, gynaecology, oncology, gastroenterology 
and cardiology. This review includes literature on the chemical com-
position of Melissa officinalis and the possibilities of its use in medi-
cine as well as functional food. Furthermore, the side effects and the 
contraindications to the usage of this herb were summarized.
Keywords: Lemon balm, Melissa officinalis L., therapeutic, herb, 
health usage 
Introduction
Melissa officinalis L. (Fig. 1) is a perennial plant in the family Lamia-
cae. It occurs naturally in the Mediterranean and West Asia. More-
over, it is cultivated widely in Europe and North America. Melissa 
is known for its characteristic lemon taste and aroma (Moradkhani 
et al., 2010). This herb is also known under other names as lemon 
balm, balm, common balm or balm mint. Notes about lemon balm 
come from the antiquity when it was described by among others 
-Hippocrates and Dioskurides. In the Middle Ages, Avicenna (980-
1037) recommended it to strengthen the heart, and Paracelsus (1493-
1541) prepared “the elixirs of life” containing the lemon balm. 
Melissa officinalis has been traditionally known for being able to 
restore youth, support weakened people and prevent baldness. In 
herbal medicine, leaf, herb and essential oil of lemon balm are used 
(SenderSki, 2009). Melissa officinalis due to its numerous health-
promoting properties, apart from medical use, is also increasingly 
used as an ingredient in supplements and functional foods. A compi-
lation of the latest data on the therapeutic properties of lemon balm 
will facilitate its application also in food products.
The chemical composition
Fresh herbs contain phenolic compounds, l-ascorbic acid, carote-
noids, flavonoids and terpenoids. Lemon balm leaves are rich in 
flavonoids (0.5 % dry weight) consist of quercitrin (a derivative of 
quercetin), ramnocitrin, luteolin and its derivatives (luteolin 7-o-β-
d-glucuronopyranoside, luteolin 3’-o-β-d-glucuronopyranoside, 
apigenin 7-o-β-d-glucopyranoside, and luteolin 7-o-β-d-gluco-
pyranoside-3’-o-β-d-glucuronopyranoside). The major components 
among terpenoids are neral. geranyl acetate, ursolic acid and tan-
nins (Moradkhani et al., 2010; Miraj et al., 2017). 0.087 g/100 g 
of caffeic acid and 21.15 g/100 g of rosmarinic acid were detected in 
the hydroethanolic extract of lemon balm leaves and phenolic com-
pounds constituted 33.97% (OżarOwski et al., 2016).
The lemon balm essential oil, secreted by glandular trichomes, has a 
pale-yellow colour with  lemony aroma (Moradkhani et al., 2010). 
Depending on the study, the amount of essential oil strongly varied, 
i.e.  0.02-0.30% of the plant weight (Moradkhani et al., 2010), 0.1% 
of herb (Sadraei et al., 2003), 0.34% of dry leaf mass (abdellatif 
et al., 2014) or 0.01-0.35% (kittler et al., 2018). The main compo-
nents of lemon balm essential oil are listed in Tab. 1.
The therapeutic properties
On the basis of the literature review, the results indicating the health-
promoting properties of lemon balm were collected. Individual stu- 
dies were conducted in vitro and in vivo, including human studies 
(Tab. 2).
Antioxidant properties − mostly the therapeutic properties of 
lemon balm based on antioxidant activities
Due to the high content of flavonoids, Melissa officinalis has anti-
oxidant properties. In vitro studies confirmed that 100-500 μg/ml of 
hydroethanolic extract from the herb had a cytoprotective activity 
against the toxic effects of hydrogen peroxide on human umbilical 
vein endothelial cells. The extract also reduced amount of hydrogen 
peroxide in intra- and extracellular fluids. This may be important 
in the prevention of cardiovascular diseases (Safaeian et al., 2016).
Antioxidative activity was examined by three methods: the ABTS 
radical cation (ABTS·+), the DPPH free radical (DPPH) and the fer-
ric reducing antioxidant power (FRAP). The activity of herb lemon 
Fig. 1:  Melissa officinalis L. 
 https://commons.wikimedia.org/wiki/Melissa_officinalis#/media/
File:Melissa_officinalis_001.JPG
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balm was comparable to respectively 10.6, 36.1 and 61.8 μM tro-
lox/100 g dry matter – trolox is a water-soluble derivative of vita- 
min E. Such antioxidant activity of lemon balm is average in com-
parison to other herbs that were analyzed (wOjdyłO et al., 2007).
The antioxidant properties were also confirmed in the study involv-
ing radiology staff exposed to long-term low-dose ionizing radia-
tion. They consumed lemon balm infusion (1.5 g dried leaves) twice 
a day for a period of 30 days. There was a significant improvement 
in the activity of catalase, superoxide dismutase and glutathione 
peroxidase in plasma as well as a reduction of DNA damage, lipid 
peroxidation and myeloperoxidase activity. Lemon balm supplemen-
tation may provide adequate protection against low-dose radiation 
(ZeraatpiShe et al., 2011).
Anti-inflammatory properties
The anti-inflammatory properties of the Melissa officinalis leaf 
oil were studied in rats with paw oedema. An oral dose of 200 or 
400 mg/kg of essential oil or 10 mg/kg of indomethacin, a drug from 
the group of non-steroidal anti-inflammatory drugs, was used. It was 
observed that both doses of lemon balm oil significantly reduced 
swelling and the effect was similar to that of a standard medicine 
(bounihi et al., 2013).
Antimicrobial properties
In in vitro tests, the essential oil of Melissa officinalis leaves had 
an inhibitory effect on the growth of Gram-positive (Staphylococcus 
aureus, Bacillus subtilis, Listeria monocytogenes) and Gram-nega-
tive (Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneu-
moniae, Salmonella enterica) bacteria, yeasts (Candida albicans, 
Saccharomyces cerevisiae) and fungi (Fusarium oxysporum spp., 
Mucor ramannianus) (abdellatif et al., 2014). The water extract of 
lemon balm leaves and rosmarinic acid also have antiviral activity. 
In in vitro studies, it inhibited the binding of HSV-1 (herpes simplex 
virus 1) to host cells and virus penetration in cells (aStani et al., 
2014). The inhibitory effect of concentrated methanolic lemon balm 
leaf extract on enterovirus 71 (EV71) has also been demonstrated 
(Chen et al., 2017).
Anxiolytic and anti-depressant properties
Lemon balm leaf is a frequently used herbal drug with anxiolytic and 
anti-depressant effect. It lowers the level of anxiety, facilitates falling 
asleep, prevents gastrointestinal disorders on the mental background 
and has sedative properties. It is usually recommended to consume 
infusions from 2-3 g of leaves 3 times a day (NOwak, 2009).
Mice subjected to chronic stress receiving aqueous extracts of Melis-
sa officinalis and Passiflora caerulea (200 mg/kg) had lower levels 
of corticosterone and higher blood glucose (feliú-heMMelMann 
et al., 2013). In the rat study, however, it was shown that only chronic 
use of lemon balm (30, 100, 300 mg/kg of ethanolic extract) had an 
anxiolytic effect. The same doses did not give a satisfactory effect 
in a single portion (TaiwO et al., 2012). It was also found that the 
antidepressant effect of lemon balm can occur by regulating 5-HT 
turnover in brain regions associated with serotoninergic neurotrans-
mission (lin et al., 2015).
In the human study, it was shown that the best concentration was 
achieved after using a single dose of 600 mg lemon balm leaf ex-
tract, a feeling of calm after eating 300 mg, however, it was necessary 
to consume as much as 900 mg to reduce the sense of “vigilance” 
(keNNedy et al., 2003). On the other hand, 600 mg of a product 
containing lemon balm leaf extracts and valerian root weakened the 
negative symptoms of anxiety (keNNedy et al., 2006).
Lemon balm used in beverages or yoghurts can also have an effect 
that improves well-being and cognitive abilities. Consumption of a 
drink containing 0.3 g of lemon balm leaf extract (containing more 
than 6% of rosmarinic acid) and additionally a natural sweetener re-
duced the level of anxiety in the subjects and improved the memory 
up to 3 hours after consumption. However, this did not affect psy-
chomotor skills. The intake of a higher dose (0.6 g) improved mathe- 
matical and psychomotor skills. Regardless of the dose, the drink 
with Melissa officinalis reduced the level of cortisol among the sub-
jects. The results of lemon balm leaf extract in yogurt were partially 
different - lower doses of lemon balm improved alertness, remember-
ing and mathematical abilities, but the use of a higher dose (0.6 g) 
was associated with a significant feeling of tiredness (schOley 
et al., 2014).
Application in sleep disorders
Melissa officinalis is a frequently used sleeping remedy for the el-
derly (lutoMSki, 2000). In a 30-day study in healthy subjects, 
360 mg of Valeriana officinalis root extract and 240 mg of Melissa 
officinalis extract consumed 0.5 h before bedtime showed to improve 
its quality. However, this did not affect the general well-being of the 
subjects (cerNy and SChMid, 1999).
A 15-day pilot study showed that in the stressed group, 600 mg of 
lemon balm leaf extract (300 mg for breakfast and 300 mg for lunch) 
reduced anxiety (15-18%) and insomnia related to anxiety (42%). In 
Tab. 1:  The content of the main components of lemon balm essential oil (%) based on the results of various researches.
Components SADRAEI et al., 2003 abdellatif et al., 2014 MEFTAHIZADE et al., 2010 MIRAJ et al., 2017 KITTLER et al., 2018 
(z)-citral (neral) 24.5 30.2 43.8 - 0.8-45.7
(e)-citral (geranial) 35.3 44.2 5.2 - 0.5-34.3
citronellal 12.9 6.3 0.01 14.4 1.3-60
β-caryophyllene 4.9 1.3 13.5 8.1 1.2-18.6
β-caryophyllene oxide 2.7 1.3 0.3 11.0 0.4-54.1
linalool 0.9 0.3 - - -
citronellol 6.2  - - -
geraniol 0.7 0.6 5.3 - -
isogeraniol - - - 6.4 -
nerol acetate - - - 5.1 -
geraniol acetate 7.1 - 2.3 10.2 -
germacrene D - - - - 0-13.6
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Tab. 2:  Summary of human studies on using Melissa officinalis
TesTed PrOPerTies aPPlied dOse TiMe OF Use OBserVed eFFecT TesT GrOUP sTUdy
Antioxidant properties 2 × 1,5 g of leaf infusion 30 days Increase in catalase, superoxide n=55 ZeraatpiShe
   dismutase, glutathione peroxidase  et al., 2011
   activity; Reduction of DNA damage, 
   lipid peroxidation, myeloperoxidase 
   activity 
Application 1200 mg of extract 3 months Reduction of PMS symptoms severity n=50 akbarZadeh et al.,   
in gynecology     2015
 1200 mg of essence 7 days/month  Reduction of PMS psychosomatic n=50 heydari et al., 2018
  for 3 months symptoms, anxiety, depression, sleep 
   problems and social problems 
 3 × 330 mg  3 days/month Reduction of systemic symptoms n=50 Mirabi et al., 2018
 of herb extract for 2 months (lethargy and fatigue) in dysmenorrhea 
 2 × 1000 mg  4 weeks Improvement in women with n=19 darviSh-Mofrad-
 of aqueous extract   hypoactive sexual desire disorder  kaShani et al., 2018
 of the dried leaves  
Anxiolytic and anti- 300 mg of leaf extract 1 day Feeling of calmness n=20 keNNedy et al., 2003
 600 mg extract of   1 day Reduction of anxiety symptoms n=24 keNNedy et al., 2006
 Melissa officinalis leaves 
 and Valeriana officinalis 
 root 
 0,3 g leaf extract  1 day Reduction of anxiety symptoms n=5 schOley et al., 2014
 (in a drink) 
 2 × 300 mg of leaf extract 15 days Reduction of anxiety, aggression n=20 CaSeS et al., 2011
   and hyperexcitation
 2 × 500 mg of leaf extract  14 days Reduction of anxiety symptoms n=28 alijaniha, 2015
 per day 
 60 drops of Melissa 16 weeks Reduction of agitation among n=42 akhondZadeh et al., 
 officinalis extract per day  patients with mild to moderate  2003
 (1:1 in 45% alcohol;   Alzheimer’s disease
 at least 500 μg citral/ml)  
Application  240 mg of Melissa 30 days Improvement of the sleep quality n=66 cerNy and SChMid, 
in sleep disorders officinalis leaves extract     1999
 and 360 mg of Valeriana 
 officinalis root extract  
 2 × 300 mg of leaf extract 15 days Reduction in insomnia frequency n=20 CaSeS et al., 2011
 2 × 160 mg of Valeriana  1 day Improvement of the sleep quality n=50 taavoni et al., 2013
 officinalis extract and   in women during menopause
 80 mg of Melissa 
 officinalis extract  
Properties supporting  600 mg of leaf extract 1 day Improvement of the concentration n=20 keNNedy et al., 2003 
 0,3 g leaf extract 1 day Improvement of the cognitive abilities n=5 schOley et al., 2014
  (in drink)
 0,6 g leaf extract   1 day Improvement of the mathematical n=5 schOley et al., 2014
 (in drink)  and psychomotor skills 
 60 drops of Melissa  16 weeks Better outcome on cognitive function n=42 akhondZadeh et al., 
 officinalis extract per day   among patients with mild to moderate  2003
 (1:1 in 45% alcohol; at   Alzheimer’s disease
 least 500 μg citral/ml)  
Application  3 × 1 g of herb extract  2 months Increased ejection fraction, higher n=35 javid et al., 2018
in cardiology   nitric oxide concentration, lower 
   lactate dehydrogenase level and 
   reduced systolic and diastolic blood 
   pressure in patients with chronic 
   stable angina 
 2 × 500 mg of leaf extract 14 days Reduction of heart rate palpitations  n=28 alijaniha, 2015
   by 36.8% 
 3 × 1000 mg of  2 months Reduction of aspartate transaminase n=28 jandaghi et al., 2016
 dried leaves  activity 
depressant properties
the functioning of the
nervous system and
cognitive functions
330 K. Świąder, K. Startek, C.H. Wijaya
addition, aggression and hyperexcitation decreased. Reductions in 
other symptoms such as eating problems, guilt and tiredness, which 
were considered to be the cause of fear, were also observed (CaSeS 
et al., 2011).
Sleep disorders in women during menopause were also examined. It 
was shown that two doses of 160 mg of Valeriana officinalis extract 
and 80 mg of Melissa officinalis extract allows to reduce the symp-
toms of sleep disorders (taavoni et al., 2013).
In the mouse study, it was found that lemon balm extract (400, 
800 mg/kg) significantly reduced the time of falling asleep and 
extended sleep time. The effect correlated positively with the dose, 
and the dose of 800 mg/kg had almost identical effect to that of dia-
zepam − a psychotropic drug. It was also shown that the mixture with 
lavender extract (Lavandula angustifolia) had a synergistic effect in 
terms of length of falling asleep and the sleep itself, which may be 
important in the treatment of insomnia (hajhaSheMi and Safaei, 
2015).
Effect on memory and neurodegenerative diseases
Numerous studies are directed to the action of Melissa officinalis in 
the prevention of memory disorders and neurodegenerative diseases. 
Melissa officinalis and rosmarinic acid can help patients with Alz-
heimer’s disease via inflammatory and neuroprotective effects as 
well as inhibition of the acetylcholine esterase activity and β-amyloid 
plaque formation in brain (Mahboubi, 2019).
The rats received intraperitoneally 50-400 mg/kg lemon balm leaf 
extract. Some of them were additionally treated with scopolamine, 
which is toxic to the nervous system. The 200 mg/kg extract signifi-
cantly improved the ability to learn and remember and diminished 
the effect of scopolamine. In addition, inhibition of acetylcholine 
esterase activity was observed (Soodi et al., 2014). In another study, 
in which rats were given a hydroethanolic extract of lemon balm 
leaves (200 mg/kg) for 28 days, an improvement in long-term memo-
ry was observed. At the same time, the level of acetylcholine esterase 
mRNA decreased in the cerebral cortex and the β-secretase mRNA 
transcription decreased, which may be important in the prevention of 
Alzheimer’s disease (OżarOwski et al., 2016). In traditional Iranian 
medicine, a mixture of lemon balm herb and Boswellia serrata oleo 
gum resin extract is used to improve the ability to remember. The use 
of 200 or 400 mg extracts from both plants in adult rats for 4 weeks 
had a protective effect against the toxic action of scopolamine on 
neurons. A better effect in memory tests could be related to antioxi-
dant and anti-inflammatory effects (Mahboubi et al., 2016).
In vitro tests have also shown that 15% aqueous leaf extract (10 μg/
ml) protects hippocampal neurons against MDMA-induced apop-
tosis (3,4-methylenedioxymethamphetamine) and lowers caspase-3 
activity (haSSanZadeh et al., 2010). The extract of the same con-
centration also had a protective effect on hypoxia in nerve cells. The 
level of caspase-3 and malondialdehyde decreased. In addition, lem-
on balm reduced the expression of the HIF-1α gene (hypoxia induced 
factor 1α). Melissa officinalis can thus be a neuroprotective factor in 
diseases related to oxidative stress (BayaT et al., 2012). It was found 
that the acid fraction of the ethanolic extract of lemon balm leaves 
(1:10) had a significant protective effect in the case of neurotoxicity 
caused by β-amyloid plaques and oxidative stress. Probably it was the 
action of polyphenols and triterpenoids through antioxidant mecha-
nisms or stimulation of nicotinic receptors, and this fraction contains 
the highest concentration of rosmarinic acid. The use of 10 μg/ml 
extract or 1 μg/ml acid fraction reversed the effects of toxicity and 
increased cell viability to its original state (Sepand et al., 2013).
The efficacy of lemon balm has also been studied in people with 
mild to moderate Alzheimer’s disease. Twenty patients received 
60 drops of leaf extract a day (1:1 with 45% alcohol, 500 μg citral/
ml) for 16 weeks and fifteen for placebo. Already from the fourth 
week of therapy, significantly better results in the cognitive assess-
ment were observed, and from the 8th week also in the assessment 
of the severity of dementia. In addition, fewer patients experienced 
agitation (psychomotor anxiety) in the group using lemon balm than 
placebo (akhondZadeh et al., 2003).
Application in ophthalmology
Macular degeneration is a common disease among older people. The 
main cause of this disease is the action of free oxygen radicals. The 
influence of hydroethanolic extract from lemon balm leaves ALS-
L1023 (6.25-200 μg/ml) on oxidative stress in human cells of the 
retinal pigment layer was investigated in vitro. The extract signifi-
cantly increased cell viability and decreased apoptosis caused by oxi- 
dative stress. This involved the inhibition of caspase-3/7 and PARP, 
which are the stimulators of apoptosis. The protective effect of lemon 
balm extract was mediated by the protein kinase B signal transduc-
tion pathway. It can be concluded that the lemon balm extract effec-
tively protects against oxidative stress induced by hydrogen peroxide 
 3 × 1 g of herb extract  2 months Reduction of anxiety, stress,  n=35 hayBar et al., 2018
   depression and sleep in patients 
   with stable angina 
 3 × 500 mg  1 week Improvement of the sleep quality and n=80 Soltanpour et al.,
 of dried leaf powder  the anxiety in patients underwent   2019
   coronary artery bypass surgery  
 700 mg/d  12 weeks Improvement of lipids, Apo A-I, n=31 aSadi et al., 2018
 of hydroalcoholic extract  Apo B/Apo A-I ratios in patients 
   with type II diabetes 
 700 mg/d  12 weeks Improvement in glycemic control, n=31 aSadi et al., 2019
 of hydroalcoholic extract  lipid profile, inflammation and 
   systolic blood pressure 
Application in  Infusion made of 1 month Reduction in body mass, BMI, n=18 jafari et al., 2018
obesity therapy 2 g of lemon balm   diastolic blood pressure
 twice a day  
Application  20% tincture 30 days No reduction in muscle activity n=12 bortoletto, 2016
in bruxism (2 × 15 drops/d)
  1 drop of homeopathic  30 days Reduction of tooth grinding n=39 tavareS-Silva et al., 
 preparations   in children with bruxism  2019 
 per year of age
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through antiapoptotic and antioxidant effects (jeung et al., 2016).
Diabetic retinopathy is another condition where medicinal plants 
are considered as a potential treatment. Due to capability to modu- 
late blood sugar and lipid levels, Melissa officinalis can be used 
for preventing diabetes complications. Rosmarinic acid also shows 
beneficial suppressing retinal neovascularization by inhibition of 
retinal endothelial cells proliferation and angiogenic tube formation 
(parveen et al., 2018).
Application in gynecology
Lemon balm is used in menstrual disorders, such as lack of or irregu-
lar menstruation, in menstrual pain and during excessive bleeding 
(kaPczyński, 2000). The use of 1,200 mg of lemon balm extract 
among high school students significantly reduced the severity of pre-
menstrual syndrome symptoms during the 3-month treatment. The 
observed positive effect concerned psychological, physiological and 
social symptoms. The regulation of the GABA-ergic system may be a 
likely mechanism for the action of Melissa officinalis (akbarZadeh 
et al., 2015). These results were confirmed by similar research in 
which female adolescents were treated with 1,200 mg of lemon balm 
essence during first 7 days of menstruation for three cycles. There 
was observed an improvement in psychosomatic symptoms, anxiety, 
sleep disturbances, depression and social dysfunction (heydari et al., 
2018).
Lemon balm seems to be helpful in reduction of systemic symp- 
toms that are associated with dysmenorrhea. Fifty students with dys-
menorrhea received 330 mg of lemon balm herb extract three times 
for three days during two menstrual cycles. Trial showed a significant 
decrease in severity of lethargy and fatigue (Mirabi et al., 2018). An-
other indication of lemon balm is hypoactive sexual desire disorder 
− the most common sexual dysfunction in women. In a randomized, 
double-blind placebo-controlled study a group of 19 women (18 to 
50 years old) consumed twice a day two capsules of Melissa offici-
nalis (containing 500 mg of aqueous extract of the dried leaves) for 
four weeks. The treatment led to the increase in frequency of sexual 
intercourse and had beneficial effects in every domain of this sexual 
dysfunction (arousal, orgasm, satisfaction, pain, lubrication, desire). 
Improvement can be connected with anti-depressive and anti-anxiety 
effects, as well as a role of increased norepinephrine and cholinergic 
activity in sexual desire and arousal (darviSh-Mofrad-kaShani 
et al., 2018).
Application in oncology
Glioblastoma multiforme is one of the most common and most fatal 
cancers of the central nervous system. The in vitro effects of aqueous 
and ethanolic extracts of lemon balm and rosmarinic acid on C6 cell 
lines of this tumour were investigated in rats. In each case, cytotoxic 
effects and suppression of proliferation were observed, however, ros-
marinic acid showed the weakest effect, and its higher doses (≥ 200 
μM) had pro-oxidative properties and initiated cell death through 
necrosis. In various ways, lemon balm can be a neuroprotective fac-
tor in the treatment of glioma (raManauSkiene et al., 2016). An 
ethanol lemon balm leaf extract of 5 μg/ml significantly reduces 
the proliferation of HCT-116 cells (human colon cancer cells), and 
at a concentration of 1,000 μg/ml significantly reduces their via- 
bility (enCalada et al., 2011). The effect of hydroethanolic extract 
of lemon balm leaf extract (5-1,000 μg/ml) on several different tu-
mour cell lines: A549 (lung cancer cells), MCF-7 (breast cancer), 
SKOV3 (ovarian cancer cells) and PC-3 (prostatic adenocarcinoma). 
Even the lowest concentrations of the extract significantly reduced 
cell viability and inhibited their growth (jahanban-eSfahlan et al., 
2015; jahanban-eSfahlan et al., 2017). Melissa officinalis extract 
was also examined as a potential treatment against human pancreatic 
cancer cells. However, this plant extracts did not show efficient as 
antitumoral agent (Mouhid et al., 2018).
Doxorubicin (DOX) is a cytostatic drug with high activity in various 
types of cancer, however, it also has a cardiotoxic effect. It was found 
that lemon balm herb extract reduced the oxidative stress caused by 
DOX − decreased lipid peroxidation, protein oxidation and increased 
antioxidant capacity. It also inhibited inflammatory reactions by 
lowering the expression of the nuclear factor κβ (NF-κβ), tumour ne-
crosis factor-α (TNF-α) and cyclooxygenase-2 and myeloperoxidase 
activity. Incorporation of lemon balm herb extract into doxorubicin 
may provide a safer cancer treatment protocol (haMZa et al., 2016).
Effect on muscle activity
Bruxism is a disorder that occurs in 13.5-33% of children, and is 
characterized by repetitive muscle activity, e.g. clenching and rub-
bing of teeth during sleep. The effect of 20% tincture from lemon 
balm (2 × 15 drops/d, 30 days) on muscle activity was studied in 
12 children aged 6-10 years. However, no reduction in muscle activ-
ity was observed in children (bortoletto, 2016). Another research 
with outcomes measured by a visual analogue scale of children’s 
teeth showed beneficial effects on bruxism. 39 children (3-12 years 
old) were treated with homeopathic preparations of M. officinalis, 
Phytolacca decandra, a combination of both or placebo (1 drop per 
year of age for 30 days). The study showed that the use of lemon balm 
can reduce tooth grinding in children with bruxism (tavareS-Silva 
et al., 2019).
Application in gastroenterology
Lemon balm can be used in the irritable bowel syndrome. In an in 
vitro study, it was demonstrated that essential oil and citral (one of 
the main components of the oil) have the effect of relieving intestinal 
spasms caused by potassium chloride, serotonin and acetylcholine 
(Sadraei et al., 2003). The possibility of modulating the visceral 
hypersensitivity by the hydroalcoholic lemon balm extract in the ir-
ritable bowel syndrome in rats is also indicated (dolatabadi et al., 
2018).
It has also been shown that the methanolic leaf extract (150, 300 and 
450 mg/kg) in single dose may have a protective effect on stomach 
ulcers in rats. The potential mechanism was to increase the activity 
of superoxide dismutase and glutathione peroxidase and inhibition of 
lipid peroxidation in cell membranes − reduction of malondialdehyde 
production (Saberi et al., 2016).
In the study involving patients with infantile colic there was a posi-
tive effect of the supply of chamomile (M. chamomilla L.), lemon 
balm and L. acidophilus (HA122). The group, that was administered 
2 ml of solution (18 mg chamomile, 130 mg lemon balm and 2 × 
109 lactic bacteria) in two doses over 28 days, showed a significant- 
ly lower incidence of crying in comparison to infants who received 
simethicone (Martinelli et al., 2017).
Application in cardiology
Melissa officinalis is considered as safe alternative to pharmaco-
therapy in mild palpitations. The use of a dry leaf extract (2 × 500 
mg/d, 14 days) among 28 people resulted in a reduction in the rate 
of palpitations by 36.8%. In addition, a decrease in anxiety symp-
toms was observed (alijaniha, 2015). In a rat study, it was found 
that the supply of lemon balm herb extract for one week (50, 100, 
200 mg/kg) was associated with changes in electrocardiographic re-
sults. The effects were similar to anti-arrhythmic drugs (joukar and 
aSadipour, 2015).
In addition, lemon balm may support hyperlipidaemia therapy. 
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In the study, various doses of ethanolic extract (25, 50 and 75 mg/
kg) were given to hypercholesterolemic rats. It was found that ir-
respective of the dose, lemon balm reduced the activity of hepatic 
enzymes: alanine aminotransferase, aspartate aminotransferase and 
alkaline phosphatase, as well as decreased the level of cholesterol in 
the blood. The effect of lemon balm was the same as atorvastatin − a 
drug commonly used to treat hyperlipidaemia (Zarei et al., 2014). A 
similar result was obtained in a study involving people with hyper- 
lipidaemia. A two-month treatment with powdered lemon balm 
leaves (3 × 1,000 mg/d) resulted in a decrease in the mean LDL level 
and aspartate aminotransferase (jandaghi et al., 2016). Melissa of-
ficinalis was also found to improve lipids and Apo A-I, Apo B/Apo 
A-I ratio in patients with type II diabetes who received 700 mg/d 
hydroalcoholic extract of lemon balm for 12 weeks. These effects 
can be useful in preventing cardiovascular diseases in this group of 
patients (aSadi et al., 2018). This treatment resulted also in a positive 
changes in glycemic control (HbA1c, activity of β-cells, fasting blood 
sugar), lipid profile (triglycerides, HDL-c), inflammation (high-sen-
sitivity C-reactive protein) and systolic blood pressure (aSadi et al., 
2019).
Medical lemon balm was also tested for the use in stable angina. In 
a double-blind study, 80 patients with this disorder were given 3 g of 
lemon balm herb extract per day or placebo. The study lasted three 
months. After this time, a higher cardiac ejection fraction, higher 
nitric oxide concentration, lower lactate dehydrogenase concentra-
tion and reduced systolic and diastolic blood pressure were found in 
the study group compared to control (javid et al., 2018). There was 
also a significant reduction of anxiety, stress, depression and sleep 
problems that are common in patients with stable angina (hayBar 
et al., 2018).
It has been shown that lemon balm can be administered to patients 
who underwent coronary artery bypass surgery due to its beneficial 
effects on anxiety and sleep disorders that are common in this group 
of patients. For a week, eighty people three times a day took 500 mg 
of lemon balm dried leaf powder or placebo. The treatment improved 
the sleep quality and reduced the anxiety in patients after coronary 
artery bypass surgery (Soltanpour et al., 2019).
Application in obesity therapy
The effectiveness of lemon balm in the treatment of obesity was also 
examined. It was used in genetically obese mice of the Ob-X mix 
(0.5 mg per day for 5 days), which consisted of Morus alba, Me-
lissa officinalis and Artemisia capillaris. It was observed that weight 
gains slowed down and visceral fat content decreased without af-
fecting other organs. Probably these components act specifically on 
adipose tissue (yOON and kiM, 2011). ALS-L1023 (made from lemon 
balm leaves by extraction with ethyl acetate) was administered to 
obese rats at 0.4 or 0.8% of the diet mass. The preparation inhibited 
the growth of body fat, significantly reduced its mass and protected 
against weight gain. Inhibition of angiogenesis and MMP activity 
was also found. ALS may be a potential method in the prevention and 
treatment of obesity (park et al., 2015). ALS-L1023 was also admin-
istered to rats on a high-fat diet. It was observed that in comparison 
with the group on a high-fat diet without supplementation there was 
a decrease in body weight (without affecting the calorie intake of 
food), alanine aminotransferase and aspartate aminotransferase as 
well as suppression of steatosis, inflammatory cell infiltration and 
collagen accumulation in the liver. Medical lemon balm may have a 
potentially positive effect in the prevention and treatment of obesity-
induced human NAFLD (kiM et al., 2017).
In the study involving twenty welders, two monthly interventions 
were used with the use of green tea or lemon balm infusions (2 × 
2 g/d). In both cases, a similar decrease in body weight, BMI index 
and diastolic blood pressure was observed (jafari et al., 2018).
Safety of use
There was no negative effect of a single dose of lemon balm extract 
(containing 100, 250 or 500 mg of rosmarinic acid) on the overall 
health and morphological and biochemical results of blood (noguChi- 
Shinohara et al., 2015). In one study, the only side-effect of us-
ing lemon balm (1,000 mg dry extract/day) was increased appetite 
(alijaniha, 2015). One of the cases described in the literature indi-
cates the risk of withdrawal syndrome with such symptoms as anxie- 
ty, irritability, decreased appetite, concentration and sleep. However, 
the described patient consumed up to 4 cups of lemon balm infusion 
per day for about 2 months, and symptoms appeared two days after 
cessation (deMirCi et al., 2015).
No adverse reactions are observed in healthy adults after a recom-
mended intake of up to 30 days or in amounts contained in food. 
Melissa officinalis has the GRAS (Generally Regarded as Safe) 
status with a maximum level of 0.5% in baked products. There are, 
however, risk statements when consumed by pregnant women, nurs-
ing women and paediatric patients, since genotoxic properties have 
been demonstrated in in vitro studies. Lemon balm should also not be 
used in people with thyroid disorders or those who use tranquilizers 
(aBUdayyak et al., 2015; Miraj et al., 2017).
The Panel on Food Additives and Nutrient Sources added to Food 
(ANS) concludes that due to the lack of an appropriate dossier sup-
porting the use of oregano and lemon balm extracts as additives, the 
safety of lemon balm extracts at the proposed uses in eight food cate- 
gories and use levels respectively 2.0 mg/kg bw/day for women and 
2.3 mg/kg bw/day for men cannot be assessed (EFSA, 2010).
Conclusions
Lemon balm can be used for both prevention and treatment. Melissa 
officinalis indicates antioxidant, anti-inflammatory, antimicrobial 
and antidepressant properties, as well as a wide range of applica-
tions in the treatment of sleep disorders, neurodegenerative diseases 
and obesity as well as in ophthalmology, gynaecology, oncology, gas-
troenterology and cardiology. Most of the therapeutic properties of 
lemon balm are based on antioxidant activities. This plant as quite 
safe and can be widely used in many fields of medicine, as well as a 
component of supplements and functional food.
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